Lu Lu And NotÉtats-Unis
List of bibliographic references
Number of relevant bibliographic references: 6.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000659 | Cong Wang ; Chen Hua ; Shuai Xia ; Weihua Li ; Lu Lu ; Shibo Jiang | Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD |
| 000E45 | Shan Su [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Sheng Ye [République populaire de Chine] ; Qianqian Qi [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Zhenxuan Ma [République populaire de Chine] ; Fei Yu [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Rongguang Zhang [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Lu Lu [République populaire de Chine] | Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors. |
| 001497 | Xiao-Yun Zeng ; Lu Lu ; Shi-Bo Jiang ; Shu-Wen Liu | [Small molecular agents against MERS-CoV infection]. |
| 001506 | Shuai Xia ; Qian Wang ; Shu-Wen Liu ; Lu Lu ; Shi-Bo Jiang | [Development of peptidic MERS-CoV entry inhibitors]. |
| 001520 | Lu Lu [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Tianlei Ying [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] | Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS) |
| 001F22 | Xiaojie Zhu [République populaire de Chine] ; Qi Liu ; Lanying Du ; Lu Lu ; Shibo Jiang | Receptor-binding domain as a target for developing SARS vaccines. |
| This area was generated with Dilib version V0.6.33. |  |